A detailed history of Versant Capital Management, Inc transactions in Takeda Pharmaceutical CO LTD stock. As of the latest transaction made, Versant Capital Management, Inc holds 24,996 shares of TAK stock, worth $378,189. This represents 0.06% of its overall portfolio holdings.

Number of Shares
24,996
Previous 25,130 0.53%
Holding current value
$378,189
Previous $373,000 3.49%
% of portfolio
0.06%
Previous 0.06%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Jul 07, 2025

SELL
$13.71 - $15.46 $1,837 - $2,071
-134 Reduced 0.53%
24,996 $386,000
Q1 2025

Apr 03, 2025

BUY
$12.89 - $15.19 $298,609 - $351,891
23,166 Added 1179.53%
25,130 $373,000
Q4 2024

Jan 02, 2025

BUY
$13.01 - $14.43 $25,551 - $28,340
1,964 New
1,964 $26,000
Q2 2019

Jul 16, 2019

SELL
$16.58 - $20.49 $165 - $204
-10 Closed
0 $0
Q1 2019

Apr 23, 2019

BUY
$16.7 - $21.52 $167 - $215
10 New
10 $0
Q1 2019

Apr 23, 2019

BUY
$16.7 - $21.52 $0 - $0
0 New
0 $0

Others Institutions Holding TAK

About TAKEDA PHARMACEUTICAL CO LTD


  • Ticker TAK
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 3,109,050,112
  • Market Cap $47B
  • Description
  • Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...
More about TAK
Track This Portfolio

Track Versant Capital Management, Inc Portfolio

Follow Versant Capital Management, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Versant Capital Management, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Versant Capital Management, Inc with notifications on news.